The FDA Approved The New Anti-Alzheimer’s Drug Leqembi. What You Need To Know

A trial found the drug slowed the progression of early-stage Alzheimer’s Disease.

Read the full post on Forbes - Healthcare

Howard Gleckman, Senior Contributor